You have free access to this content

Hepatology

Cover image for Vol. 59 Issue 4

April 2014

Volume 59, Issue 4

Pages 1217–1656

  1. Hepatology Highlights

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Hepatology highlights (pages 1217–1219)

      Jean-François Dufour

      Version of Record online: 24 MAR 2014 | DOI: 10.1002/hep.27075

  2. Editorials

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
    2. You have free access to this content
      New highlights for relaxin (pages 1223–1224)

      Klaas Poelstra

      Version of Record online: 20 FEB 2014 | DOI: 10.1002/hep.26713

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus (pages 1250–1261)

      Nikolaus Jilg, Wenyu Lin, Jian Hong, Esperance A. Schaefer, David Wolski, James Meixong, Kaku Goto, Cynthia Brisac, Pattranuch Chusri, Dahlene N. Fusco, Stephane Chevaliez, Jay Luther, Kattareeya Kumthip, Thomas J. Urban, Lee F. Peng, Georg M. Lauer and Raymond T. Chung

      Version of Record online: 14 FEB 2014 | DOI: 10.1002/hep.26653

    2. You have free access to this content
    3. You have free access to this content
      The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis (pages 1273–1282)

      Darragh Duffy, Rasha Mamdouh, Melissa Laird, Charlotte Soneson, Lenaig Le Fouler, Maï El-Daly, Armanda Casrouge, Jérémie Decalf, Amal Abbas, Noha Sharaf Eldin, Magnus Fontes, Mohamed Abdel-Hamid, Mostafa K. Mohamed, Mona Rafik, Arnaud Fontanet and Matthew L. Albert

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26901

    4. You have free access to this content
      The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study (pages 1283–1292)

      Jian Sun, Qing Xie, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Rong Fan, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia and Jinlin Hou

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26885

    5. You have free access to this content
      Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients (pages 1293–1302)

      Yao-Chun Hsu, Jaw-Town Lin, Hsiu J. Ho, Yu-Hsi Kao, Yen-Tsung Huang, Nai-Wan Hsiao, Ming-Shiang Wu, Yi-Ya Liu and Chun-Ying Wu

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26892

    6. You have free access to this content
      Assessment of current criteria for primary nonresponse in chronic hepatitis B patients receiving entecavir therapy (pages 1303–1310)

      Young-Joo Yang, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim and Han Chu Lee

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26910

    7. You have free access to this content
      Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study (pages 1311–1319)

      Norah A. Terrault, R. Todd Stravitz, Anna S.F. Lok, Greg T. Everson, Robert S. Brown Jr., Laura M. Kulik, Kim M. Olthoff, Sammy Saab, Ovedele Adeyi, Curtis K. Argo, Jay E. Everhart, Del R. Rodrigo and the A2ALL Study Group

      Version of Record online: 1 MAR 2014 | DOI: 10.1002/hep.26920

    8. You have full text access to this OnlineOpen article
      Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner (pages 1320–1330)

      Nicola F. Fletcher, Rupesh Sutaria, Juandy Jo, Amy Barnes, Miroslava Blahova, Luke W. Meredith, Francois-Loic Cosset, Stuart M. Curbishley, David H. Adams, Antonio Bertoletti and Jane A. McKeating

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26911

    9. You have free access to this content
      Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment (pages 1331–1342)

      Juanjuan Zhao, Zheng Zhang, Yan Luan, Zhengsheng Zou, Yanling Sun, Yonggang Li, Lei Jin, Chunbao Zhou, Junliang Fu, Bin Gao, Yangxin Fu and Fu-Sheng Wang

      Version of Record online: 1 MAR 2014 | DOI: 10.1002/hep.26916

    10. You have full text access to this OnlineOpen article
      Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection (pages 1343–1350)

      Sam Lattimore, Will Irving, Sarah Collins, Celia Penman, Mary Ramsay and on Behalf of the Collaboration for the Sentinel Surveillance of Blood-Borne Virus Testing

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26926

    11. You have full text access to this OnlineOpen article
  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice (pages 1366–1380)

      Rohit A. Sinha, Benjamin L. Farah, Brijesh K. Singh, Monowarul M. Siddique, Ying Li, Yajun Wu, Olga R. Ilkayeva, Jessica Gooding, Jianhong Ching, Jin Zhou, Laura Martinez, Sherwin Xie, Boon-Huat Bay, Scott A. Summers, Christopher B. Newgard and Paul M. Yen

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26667

    2. You have free access to this content
    3. You have free access to this content
      The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease (pages 1393–1405)

      Victoria L. Gadd, Richard Skoien, Elizabeth E. Powell, Kevin J. Fagan, Clay Winterford, Leigh Horsfall, Katharine Irvine and Andrew D. Clouston

      Version of Record online: 1 MAR 2014 | DOI: 10.1002/hep.26937

    4. You have free access to this content
      Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis (pages 1406–1414)

      Ju Dong Yang, Manal F. Abdelmalek, Herbert Pang, Cynthia D. Guy, Alastair D. Smith, Anna Mae Diehl and Ayako Suzuki

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26761

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have full text access to this OnlineOpen article
      Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma (pages 1415–1426)

      Tobias Flecken, Nathalie Schmidt, Sandra Hild, Emma Gostick, Oliver Drognitz, Robert Zeiser, Peter Schemmer, Helge Bruns, Thomas Eiermann, David A. Price, Hubert E. Blum, Christoph Neumann-Haefelin and Robert Thimme

      Version of Record online: 20 FEB 2014 | DOI: 10.1002/hep.26731

    2. You have free access to this content
      Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma (pages 1427–1434)

      Yasuhito Arai, Yasushi Totoki, Fumie Hosoda, Tomoki Shirota, Natsuko Hama, Hiromi Nakamura, Hidenori Ojima, Koh Furuta, Kazuaki Shimada, Takuji Okusaka, Tomoo Kosuge and Tatsuhiro Shibata

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26890

    3. You have free access to this content
      Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice (pages 1435–1447)

      Yunching Chen, Yuhui Huang, Thomas Reiberger, Annique M. Duyverman, Peigen Huang, Rekha Samuel, Lotte Hiddingh, Sylvie Roberge, Christina Koppel, Gregory Y. Lauwers, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26790

    4. You have free access to this content
      Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma (pages 1448–1458)

      Yuan Hong, Yibing Peng, Z. Sheng Guo, Jose Guevara-Patino, Junfeng Pang, Lisa H. Butterfield, Nahid F. Mivechi, David H. Munn, David L. Bartlett and Yukai He

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26893

    5. You have free access to this content
      Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma (pages 1459–1470)

      Hua Tian, Chao Ge, Hong Li, Fangyu Zhao, Helei Hou, Taoyang Chen, Guoping Jiang, Haiyang Xie, Ying Cui, Ming Yao and Jinjun Li

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26929

    6. You have free access to this content
      Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach (pages 1471–1481)

      Abbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, Thibaud Renaut-Vantroys, Isabelle Rosa, Anne-Marie Bouvier, Guy Launoy, Stephane Cattan, Alexandre Louvet, Sébastien Dharancy, Jean-Claude Trinchet, Yazdan Yazdanpanah and Philippe Mathurin

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26944

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have full text access to this OnlineOpen article
      Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: A prospective population-based case-control study (pages 1482–1491)

      Victoria Geenes, Lucy C. Chappell, Paul T. Seed, Philip J. Steer, Marian Knight and Catherine Williamson

      Version of Record online: 26 FEB 2014 | DOI: 10.1002/hep.26617

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo (pages 1492–1504)

      Jonathan A. Fallowfield, Annette L. Hayden, Victoria K. Snowdon, Rebecca L. Aucott, Ben M. Stutchfield, Damian J. Mole, Antonella Pellicoro, Timothy T. Gordon-Walker, Alexander Henke, Joerg Schrader, Palak J. Trivedi, Marc Princivalle, Stuart J. Forbes, Jane E. Collins and John P. Iredale

      Version of Record online: 3 MAR 2014 | DOI: 10.1002/hep.26627

    2. You have free access to this content
      Type-1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival (pages 1505–1513)

      Rogelio Barreto, Claudia Fagundes, Mónica Guevara, Elsa Solà, Gustavo Pereira, Ezequiel Rodríguez, Isabel Graupera, Marta Martín-Llahí, Xavier Ariza, Andrés Cárdenas, Javier Fernández, Juan Rodés, Vicente Arroyo and Pere Ginès

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26687

    3. You have free access to this content
      Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: Validation of current recommendations (pages 1514–1521)

      Claire Francoz, Mitra K. Nadim, Aurore Baron, Dominique Prié, Corinne Antoine, Jacques Belghiti, Dominique Valla, Richard Moreau and François Durand

      Version of Record online: 3 MAR 2014 | DOI: 10.1002/hep.26704

    4. You have free access to this content
      Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis (pages 1522–1531)

      Vandréa De Souza, Aoumeur Hadj-Aissa, Olga Dolomanova, Muriel Rabilloud, Nicolas Rognant, Sandrine Lemoine, Sylvie Radenne, Jérôme Dumortier, Colette Chapuis-Cellier, Françoise Beyerle, Chantal Bon, Jean Iwaz, Luciano Selistre and Laurence Dubourg

      Version of Record online: 24 MAR 2014 | DOI: 10.1002/hep.26886

    5. You have free access to this content
      Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis (pages 1532–1542)

      Ayse L. Mindikoglu, Thomas C. Dowling, Matthew R. Weir, Stephen L. Seliger, Robert H. Christenson and Laurence S. Magder

      Version of Record online: 30 SEP 2013 | DOI: 10.1002/hep.26556

  8. Liver Injury/Regeneration

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Protein kinase C (PKC) participates in acetaminophen hepatotoxicity through c-jun-N-terminal kinase (JNK)-dependent and -independent signaling pathways (pages 1543–1554)

      Behnam Saberi, Maria D. Ybanez, Heather S. Johnson, William A. Gaarde, Derick Han and Neil Kaplowitz

      Version of Record online: 3 MAR 2014 | DOI: 10.1002/hep.26625

    2. You have free access to this content
      Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice (pages 1555–1563)

      Elea Conrad, Theresa K. Resch, Patricia Gogesch, Ulrich Kalinke, Ingo Bechmann, Christian Bogdan and Zoe Waibler

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26915

    3. You have free access to this content
      Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure (pages 1564–1576)

      Charalambos Gustav Antoniades, Wafa Khamri, Robin D. Abeles, Leonie S. Taams, Evangelos Triantafyllou, Lucia A. Possamai, Christine Bernsmeier, Ragai R. Mitry, Alistair O'Brien, Derek Gilroy, Robert Goldin, Michael Heneghan, Nigel Heaton, Wayel Jassem, William Bernal, Diego Vergani, Yun Ma, Alberto Quaglia, Julia Wendon and Mark Thursz

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26933

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma (pages 1577–1590)

      Bryan C. Fuchs, Yujin Hoshida, Tsutomu Fujii, Lan Wei, Suguru Yamada, Gregory Y. Lauwers, Christopher M. McGinn, Danielle K. DePeralta, Xintong Chen, Toshihiko Kuroda, Michael Lanuti, Anthony D. Schmitt, Supriya Gupta, Andrew Crenshaw, Robert Onofrio, Bradley Taylor, Wendy Winckler, Nabeel Bardeesy, Peter Caravan, Todd R. Golub and Kenneth K. Tanabe

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26898

    2. You have free access to this content
      Inhibition of Niemann-Pick-type C1-like1 by ezetimibe activates autophagy in human hepatocytes and reduces mutant α1-antitrypsin Z deposition (pages 1591–1599)

      Takeshi Yamamura, Yuki Ohsaki, Michitaka Suzuki, Yuki Shinohara, Tsuyako Tatematsu, Jinglei Cheng, Masato Okada, Naoki Ohmiya, Yoshiki Hirooka, Hidemi Goto and Toyoshi Fujimoto

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26930

    3. You have free access to this content
      Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice (pages 1600–1616)

      Xiaodong Ge, Tung-Ming Leung, Elena Arriazu, Yongke Lu, Raquel Urtasun, Brian Christensen, Maria Isabel Fiel, Satoshi Mochida, Esben S. Sørensen and Natalia Nieto

      Version of Record online: 1 MAR 2014 | DOI: 10.1002/hep.26931

  10. New Horizons

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Liver regeneration by stem/progenitor cells (pages 1617–1626)

      Tohru Itoh and Atsushi Miyajima

      Version of Record online: 14 FEB 2014 | DOI: 10.1002/hep.26753

  11. Review

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Pulmonary complications in chronic liver disease (pages 1627–1637)

      Victor I. Machicao, Maya Balakrishnan and Michael B. Fallon

      Version of Record online: 25 FEB 2014 | DOI: 10.1002/hep.26745

  12. Hepatology Elsewhere

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
    2. You have free access to this content
  13. Clinical Observations in Hepatology

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
  14. Correspondence

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      Hepcidin as a predictor of treatment response in chronic hepatitis C infection (page 1648)

      Pavel Strnad, Renwar Nuraldeen, Janett Fischer, Thomas Berg and Christian Trautwein

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26656

    2. You have free access to this content
      Reply (pages 1648–1649)

      John Denis Ryan, Sandro Altamura, Martina Muckenthaler and John Crowe

      Version of Record online: 14 FEB 2014 | DOI: 10.1002/hep.26764

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
      Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels? (pages 1650–1651)

      Jason Grebely, Bart Grady, Behzad Hajarizadeh, Kimberly Page, Gregory J. Dore and On Behalf of the INC Study Group

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26675

    6. You have free access to this content
      Reply (page 1651)

      Mazen Noureddin, Elizabeth C. Wright and Marc G. Ghany

      Version of Record online: 5 MAR 2014 | DOI: 10.1002/hep.26690

    7. You have free access to this content
    8. You have free access to this content
      Reply (pages 1652–1653)

      Yao-Chun Hsu and Chun-Ying Wu

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26691

    9. You have free access to this content
    10. You have free access to this content
      Reply (pages 1653–1654)

      Sasan Roayaie

      Version of Record online: 18 FEB 2014 | DOI: 10.1002/hep.26688

  15. Obituary

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. New Horizons
    12. Review
    13. Hepatology Elsewhere
    14. Clinical Observations in Hepatology
    15. Correspondence
    16. Obituary
    1. You have free access to this content
      In memoriam: Burton Combes, M.D. (pages 1655–1656)

      Steven Schenker

      Version of Record online: 24 MAR 2014 | DOI: 10.1002/hep.27051

SEARCH

SEARCH BY CITATION